Clobetasol propionate Completed Phase 1 Trials for Atopic Dermatitis (AD) Other

IndicationsStatusPurposePhase
CompletedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT01381445A Study Assessing GW870086's Potential to Cause Skin Thinning